Works about IMMUNE checkpoint proteins

Results: 5000

Urine tumor DNA detection of minimal residual disease in muscle-invasive bladder cancer treated with curative-intent radical cystectomy: A cohort study.

Published in:

2021

By:

Chauhan, Pradeep S.;
Chen, Kevin;
Babbra, Ramandeep K.;
Feng, Wenjia;
Pejovic, Nadja;
Nallicheri, Armaan;
Harris, Peter K.;
Dienstbach, Katherine;
Atkocius, Andrew;
Maguire, Lenon;
Qaium, Faridi;
Szymanski, Jeffrey J.;
Baumann, Brian C.;
Ding, Li;
Cao, Dengfeng;
Reimers, Melissa A.;
Kim, Eric H.;
Smith, Zachary L.;
Arora, Vivek K.;
Chaudhuri, Aadel A.

Publication type:

journal article

Special Issue Abstracts from the American Society for Apheresis 45th Annual Meeting April 17–19, 2024.

Published in:: Journal of Clinical Apheresis, 2024, v. 39, n. 2, p. 1, doi. 10.1002/jca.22113
Publication type:: Article

Pan-cancer analysis reveals RIPK2 predicts prognosis and promotes immune therapy resistance via triggering cytotoxic T lymphocytes dysfunction.

Published in:

Molecular Medicine, 2022, v. 28, n. 1, p. 1, doi. 10.1186/s10020-022-00475-8

By:

Song, Junquan;
Yang, Runyu;
Wei, Rongyuan;
Du, Yue;
He, Pengcheng;
Liu, Xiaowen

Publication type:

Article

Inhibitory immune checkpoints PDCD-1 and LAG-3 hypermethylation may reduce the risk of colorectal cancer.

Published in:

Molecular Medicine, 2021, v. 27, n. 1, p. 1, doi. 10.1186/s10020-021-00373-5

By:

Zhang, Yuanyuan;
zhang, Lei;
Sun, Hongru;
Liu, Ying;
Xu, Jing;
Huang, Hao;
Fu, Jinming;
Zhang, Ding;
Tian, Tian;
Zhao, Yashuang;
Wang, Guiyu

Publication type:

Article

Chimeric Antigen Receptor (CAR)‐T Cells: A New Era for Hepatocellular Carcinoma Treatment.

Published in:

Journal of Biochemical & Molecular Toxicology, 2024, v. 38, n. 12, p. 1, doi. 10.1002/jbt.70091

By:

Xu, Ming;
Pan, Yang

Publication type:

Article

Role of PD‐1 in modulating IFN‐γ‐CXCL9/10‐CXCR3 signaling in breast cancer.

Published in:

Journal of Biochemical & Molecular Toxicology, 2024, v. 38, n. 12, p. 1, doi. 10.1002/jbt.23842

By:

Hong, Lei;
Huang, Fang;
Hu, Zexian;
Dong, Qian;
Kong, Yan;
Zheng, Xuan;
Li, Man;
Cui, Yanzhi

Publication type:

Article

Diet restriction enhances the effect of immune checkpoint block by inhibiting the intratumoral mTORC1/B7‐H3 axis.

Published in:

Journal of Biochemical & Molecular Toxicology, 2024, v. 38, n. 8, p. 1, doi. 10.1002/jbt.23803

By:

Xiao, Duqing;
Liu, Tingting;
Pan, Youguang

Publication type:

Article

Serpin family H member 1 and its related collagen gene network are the potential prognostic biomarkers and anticancer targets for glioma.

Published in:

Journal of Biochemical & Molecular Toxicology, 2024, v. 38, n. 1, p. 1, doi. 10.1002/jbt.23541

By:

Wang, Qi;
Wang, Zhe

Publication type:

Article

Bakuchiol inhibits lung cancer by modulating tumor microenvironment and the expression of PD‐L1.

Published in:

Journal of Biochemical & Molecular Toxicology, 2023, v. 37, n. 9, p. 1, doi. 10.1002/jbt.23401

By:

Lin, Mengxin;
Xu, Qian;
Luo, Yang;
Liu, Gaohua;
Hou, Peifeng

Publication type:

Article

Identification of Grb2‐associated binding protein 3 expression to predict clinical outcomes and immunotherapeutic responses in lung adenocarcinoma.

Published in:

Journal of Biochemical & Molecular Toxicology, 2022, v. 36, n. 10, p. 1, doi. 10.1002/jbt.23166

By:

Wang, Ning;
Zhou, Xue;
Wang, Xue;
Zhu, Xiaowei

Publication type:

Article

SLAM receptors regulate immune checkpoints via SAP and EAT- 2 in rheumatoid arthritis: association with disease activity.

Published in:

Clinical Rheumatology, 2025, v. 44, n. 6, p. 2201, doi. 10.1007/s10067-025-07461-5

By:

Malekan, Mohammad;
Dozandeh-Jouybari, Armin;
Sadeghian, Najmeh;
Soltanshahi, Mohsen;
Azadeh, Hossein;
Ajami, Abolghasem;
Asgarian-Omran, Hossein;
Taghiloo, Saeid

Publication type:

Article

Chronic non-bacterial osteomyelitis and immune checkpoint molecules.

Published in:

Clinical Rheumatology, 2024, v. 43, n. 1, p. 553, doi. 10.1007/s10067-023-06761-y

By:

Kaya Akca, Ummusen;
Sag, Erdal;
Aydın, Busra;
Tasdemir, Nur Kubra;
Kasap Cuceoglu, Muserref;
Basaran, Ozge;
Batu, Ezgi Deniz;
Bilginer, Yelda;
Ozen, Seza

Publication type:

Article

PD-L1 expression in high-risk non-muscle invasive bladder cancer is not a biomarker of response to BCG.

Published in:

World Journal of Urology, 2025, v. 43, n. 1, p. 1, doi. 10.1007/s00345-024-05392-5

By:

de Jong, Florus C.;
Kvikstad, Vebjørn;
Hoedemaeker, Robert F.;
van der Made, Angelique C. J.;
van der Bosch, Thierry P.;
van Casteren, Niels J.;
van Kessel, Kim E. M.;
Zwarthoff, Ellen C.;
Boormans, Joost L.;
Zuiverloon, Tahlita C. M.

Publication type:

Article

Multi-detector computed tomography (MDCT)–based severity score as a prognostic tool in patients with suspected immune checkpoint inhibitor therapy associated colitis.

Published in:

European Radiology, 2021, v. 31, n. 12, p. 8868, doi. 10.1007/s00330-021-07925-7

By:

Pisuchpen, Nisanard;
Durbin, Sienna M.;
Mooradian, Meghan J.;
Fintelmann, Florian J.;
Reynolds, Kerry L.;
Dougan, Michael;
Kambadakone, Avinash

Publication type:

Article

Intrahepatic cholangiocarcinoma: MRI texture signature as predictive biomarkers of immunophenotyping and survival.

Published in:

2021

By:

Zhang, Jun;
Wu, Zhenru;
Zhao, Jian;
Liu, Siyun;
Zhang, Xin;
Yuan, Fang;
Shi, Yujun;
Song, Bin

Publication type:

journal article

Pan-Cancer Analysis of the Prognostic and Immunological Role of SMG5: A Biomarker for Cancers.

Published in:

Oncology, 2024, v. 102, n. 2, p. 168, doi. 10.1159/000533421

By:

Yang, Leteng;
Wei, Jie;
Ma, Xiaoya;
Cheng, Rui;
Zhang, Huan;
Jin, Tianbo

Publication type:

Article

An Extremely Rare Case of Immune Checkpoint Inhibitors–Related Hypoparathyroidism and a Critical Literature Review Open Access.

Published in:

JCEM Case Reports, 2025, v. 3, n. 6, p. 1, doi. 10.1210/jcemcr/luaf097

By:

Kazanas, Spyridon;
Anastasopoulou, Amalia;
Ziogas, Dimitrios;
Gogas, Helen;
Angelousi, Anna

Publication type:

Article

Nothing Great Comes Without Its Risks: A Rare Case of Pembrolizumab-Induced Hypophysitis.

Published in:

JCEM Case Reports, 2024, v. 2, n. 1, p. 1, doi. 10.1210/jcemcr/luad135

By:

Fernando, Ashen;
Mittal, Aastha;
Cheema, Rashid

Publication type:

Article

Marked Hypoleptinemia Precedes Overt Fat Loss in Immune Checkpoint Inhibitor-induced Acquired Generalized Lipodystrophy.

Published in:

JCEM Case Reports, 2023, v. 1, n. 2, p. 1, doi. 10.1210/jcemcr/luad025

By:

Dhanasekaran, Maheswaran;
Sandooja, Rashi;
Higgins, Alexandra S;
Simha, Vinaya

Publication type:

Article

A multi-type programmed cell death gene signature predicts survival and reveals therapeutic targets in osteosarcoma.

Published in:

Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-02944-y

By:

Wu, Chunyang

Publication type:

Article

Integrative transcriptomic and single-cell analysis reveals IL27RA as a key immune regulator and therapeutic indicator in breast cancer.

Published in:

Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-02811-w

By:

Chen, Yi;
Anwar, Munawar;
Wang, Xiaoli;
Zhang, Boxiang;
Ma, Binlin

Publication type:

Article

Unraveling the immunomodulatory role of TIM-3 in head and neck squamous cell carcinoma: implications for targeted therapy.

Published in:

Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-02673-2

By:

Xu, Shuang;
Luo, Yang;
He, Yuzhu;
Chen, Yuxiang;
Qin, Fengfeng;
Hu, Wenjian

Publication type:

Article

The immunosuppressive role of VSIG4 in colorectal cancer and its interaction with the tumor microenvironment.

Published in:

Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-02411-8

By:

Zhang, H. G.;
Yao, W. R.;
Zhou, Z. Y.;
Liu, L.

Publication type:

Article

Comprehensive pan-cancer analysis of PPP1R3G reveals its diagnostic, prognostic, and immunotherapeutic implications.

Published in:

Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-02361-1

By:

Zhang, Nie;
Li, Jiaoyu;
Ren, Yanzhi;
Xu, Yahui

Publication type:

Article

Quantifying CD73 expression after chemotherapy or chemoradiotherapy in esophageal squamous cell carcinoma.

Published in:

Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-02179-x

By:

Cooper, Zachary A.;
Wang, Ying;
Martin, Philip L.;
Murayama, Kosho;
Kumar, Rakesh;
Kato, Ken;
Yamamoto, Shun;
Sekine, Shigeki

Publication type:

Article

ERCC3 serves as a prognostic biomarker for hepatocellular carcinoma and positively regulates cell proliferation and migration.

Published in:

Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-02194-y

By:

Yang, Chen;
Du, Jiahui;
Qiu, Xiuqin;
Jia, Changhong;
Ding, Cunbao;
Wu, Yijie;
Gao, Chaoxu;
Wang, Weijie;
Wang, Xiaojun;
Liu, Song-Bai

Publication type:

Article

Pan-cancer analysis predicts MBOAT2 as a potential new ferroptosis related gene immune checkpoint.

Published in:

Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-02078-1

By:

Xie, Yuhan;
Zhang, Shichao;
Wu, Yu;
Qi, Yuanjiong;
Qi, Shiyong;
Chen, Xiuju;
Chen, Bing

Publication type:

Article

SIGLEC1 has the potential to be an immune-related prognostic indicator in colon adenocarcinoma: a study based on transcriptomic data and Mendelian randomization analysis.

Published in:

Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-02093-2

By:

Gu, Jue;
Wang, Yaxuan;
Zhang, Hui;
Gu, Haijuan;
Zhu, Haixia

Publication type:

Article

Dynamic changes in peripheral blood immunophenotyping and its prognostic value in cervical cancer patients undergoing immune checkpoint blockade therapy.

Published in:

Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-01943-3

By:

Gong, Wenjian;
Wang, Zhi;
Wei, Yongqiang;
Wang, Maomao;
Li, Kuina;
Chen, Xiaoqi;
Huang, Xiaoling;
Zhou, Lu;
Gan, Qiuting;
Xu, Xiaoying;
Huang, Zhijiong;
Yao, Hongyu;
Wu, Nengxian;
Huang, Lu;
Yan, Bingbing;
Zhao, Bingbing;
Yang, Zhijun

Publication type:

Article

Development of a prognostic model based on four genes related to exhausted CD8+ T cell in triple-negative breast cancer patients: a comprehensive analysis integrating scRNA-seq and bulk RNA-seq.

Published in:

Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-01812-z

By:

Shi, Yulin;
Yu, Yang;
Zhao, Jiahan;
Huang, Linan;
Wang, Qingyang;
Sun, Qi;
Liu, Lijuan;
Sun, Changgang

Publication type:

Article

NOL-7 serves as a potential prognostic-related biomarker for hepatocellular carcinoma.

Published in:

Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-024-01551-7

By:

Lei, Qiucheng;
Huang, Yingchun;
Deng, Feiwen;
Zheng, Huazhen;
Hong, Xitao;
Wang, Peng;
Lv, Jin;
Chen, Huanwei;
Ji, Zhenling

Publication type:

Article

Immune checkpoint B7-H3 is a potential therapeutic target in prostate cancer.

Published in:

Discover Oncology, 2024, v. 15, n. 1, p. 1, doi. 10.1007/s12672-024-01674-x

By:

Shen, Qi;
Zhou, Kaichen;
Lu, Haosen;
Zhang, Jielin;
Xu, Qiqing;
Zhang, Chengsi;
Yang, Chunhua;
Mao, Lijun

Publication type:

Article

Machine learning reveals CAT gene as a novel potential diagnostic and prognostic biomarker in non-small cell lung cancer.

Published in:

Discover Oncology, 2024, v. 15, n. 1, p. 1, doi. 10.1007/s12672-024-01670-1

By:

Tian, Yi;
Zhao, Wen-ya;
Liu, Yi-ru;
Song, Wen-wen;
Lin, Qiao-xin;
Gong, Yan-na;
Deng, Yi-ting;
Gu, Dian-na;
Tian, Ling

Publication type:

Article

Identification of BRCA new prognostic targets and neoantigen candidates from fusion genes.

Published in:

Discover Oncology, 2024, v. 15, n. 1, p. 1, doi. 10.1007/s12672-024-01571-3

By:

Zhang, Pei;
Chu, Qingzhao

Publication type:

Article

LAG-3 as a therapeutic target in melanoma.

Published in:

Oncology in Clinical Practice (2450-1654), 2025, v. 21, n. 2, p. 121, doi. 10.5603/ocp.99115

By:

Terlecka, Anna M.;
Rutkowski, Piotr;
Sobczuk, Paweł

Publication type:

Article

Nivolumab in the treatment of thoracic cancer -- new possibilities.

Published in:

Oncology in Clinical Practice (2450-1654), 2023, v. 19, n. 4, p. 299, doi. 10.5603/OCP.2022.0033

By:

Knetki-Wróblewska, Magdalena;
Wojas-Krawczyk, Kamila

Publication type:

Article

Epithelioid inflammatory myofibroblastic sarcoma of the lung ALK+/NTRK+/PD-L1+.

Published in:

Oncology in Clinical Practice (2450-1654), 2023, v. 19, n. 2, p. 129, doi. 10.5603/OCP.2022.0049

By:

Gaggero, Gabriele;
Taietti, Davide;
Parrella, Veronica;
Gennaioli, Camilla;
Guadagno, Antonio

Publication type:

Article

Current Options for Second-Line Systemic Therapy in Metastatic Renal Cell Carcinoma.

Published in:

Journal of Kidney Cancer & VHL, 2022, v. 9, n. 3, p. 29, doi. 10.15586/jkcvhl.v9i3.243

By:

Mitsogiannis, Iraklis C.;
Mitsogianni, Maria;
Papathanassiou, Maria;
Anagnostou, Maria;
Tamposis, Ioannis;
Mitrakas, Lampros;
Samara, Maria;
Tzortzis, Vassilios;
Vlachostergios, Panagiotis J.

Publication type:

Article

Single-cell RNA sequencing reveals tumor heterogeneity in small cell neuroendocrine cervical carcinoma.

Published in:

Communications Biology, 2025, v. 8, n. 1, p. 1, doi. 10.1038/s42003-025-07605-y

By:

Xiang, Xuesong;
Tao, Xiang;
Hua, Keqin;
Jiang, Hua;
Ding, Jingxin

Publication type:

Article

Capsanthin inhibits migration and reduces N-linked glycosylation of PD-L1 via the EZH2-PD-L1 axis in triple-negative breast cancer brain metastasis.

Published in:

Cell Death Discovery, 2025, v. 11, n. 1, p. 1, doi. 10.1038/s41420-025-02368-1

By:

Chien, Yi-Chung;
Wu, Jia-Yan;
Liu, Liang-Chih;
Yu, Yung-Luen

Publication type:

Article

Tri-specific tribodies targeting 5T4, CD3, and immune checkpoint drive stronger functional T-cell responses than combinations of antibody therapeutics.

Published in:

Cell Death Discovery, 2025, v. 11, n. 1, p. 1, doi. 10.1038/s41420-025-02329-8

By:

Passariello, Margherita;
Manna, Lorenzo;
Rapuano Lembo, Rosa;
Yoshioka, Asami;
Inoue, Toshikazu;
Kajiwara, Kentaro;
Hashimoto, Shu‑ichi;
Nakamura, Koji;
De Lorenzo, Claudia

Publication type:

Article

The miRNA and PD-1/PD-L1 signaling axis: an arsenal of immunotherapeutic targets against lung cancer.

Published in:

Cell Death Discovery, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41420-024-02182-1

By:

Yadav, Ritu;
Khatkar, Rinku;
Yap, Kenneth C-H;
Kang, Chloe Yun-Hui;
Lyu, Juncheng;
Singh, Rahul Kumar;
Mandal, Surojit;
Mohanta, Adrija;
Lam, Hiu Yan;
Okina, Elena;
Kumar, Rajiv Ranjan;
Uttam, Vivek;
Sharma, Uttam;
Jain, Manju;
Prakash, Hridayesh;
Tuli, Hardeep Singh;
Kumar, Alan Prem;
Jain, Aklank

Publication type:

Article

Immunometabolism in cancer: basic mechanisms and new targeting strategy.

Published in:

Cell Death Discovery, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41420-024-02006-2

By:

Su, Ranran;
Shao, Yingying;
Huang, Manru;
Liu, Donghui;
Yu, Haiyang;
Qiu, Yuling

Publication type:

Article

Deciphering the potential role of PGRN in regulating CD8<sup>+</sup> T cell antitumor immunity.

Published in:

Cell Death Discovery, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41420-024-02001-7

By:

Zhang, Wenyu;
Qin, Huan;
Wang, Guosheng;
Zhang, Jing;
He, Wenjuan;
Feng, Chunmei;
Wan, Huimin;
Wang, Feilong;
Guo, Zhongliang

Publication type:

Article

Molecular profiling of a bladder cancer with very high tumour mutational burden.

Published in:

Cell Death Discovery, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41420-024-01883-x

By:

Scimeca, Manuel;
Bischof, Julia;
Bonfiglio, Rita;
Nale, Elisabetta;
Iacovelli, Valerio;
Carilli, Marco;
Vittori, Matteo;
Agostini, Massimiliano;
Rovella, Valentina;
Servadei, Francesca;
Giacobbi, Erica;
Candi, Eleonora;
Shi, Yufang;
Melino, Gerry;
Mauriello, Alessandro;
Bove, Pierluigi

Publication type:

Article

Dual inhibitors of DNMT and HDAC induce viral mimicry to induce antitumour immunity in breast cancer.

Published in:

Cell Death Discovery, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41420-024-01895-7

By:

Huang, Wenjun;
Zhu, Qingyun;
Shi, Zhichao;
Tu, Yao;
Li, Qinyuan;
Zheng, Wenwen;
Yuan, Zigao;
Li, Lulu;
Zu, Xuyu;
Hao, Yue;
Chu, Bizhu;
Jiang, Yuyang

Publication type:

Article

Radiotherapy and immunotherapy.

Published in:

Nowotwory, 2023, v. 73, n. 1, p. 22, doi. 10.5603/NJO.a2022.0062

By:

Sierko, Ewa

Publication type:

Article

Dynamic Neutrophil Subsets and Function in Lung Transplant Recipients: Insights from a One-Year Longitudinal Pilot Study.

Published in:

Journal of Clinical Medicine, 2025, v. 14, n. 8, p. 2660, doi. 10.3390/jcm14082660

By:

Kaisar-Iluz, Naomi;
Shaul, Merav E.;
Deri, Ofir;
Huszti, Ella;
Peled, Michael;
Bezalel, Yael;
Fridlender, Zvi G.;
Levy, Liran

Publication type:

Article

Advancements in Melanoma Treatment: A Review of PD-1 Inhibitors, T-VEC, mRNA Vaccines, and Tumor-Infiltrating Lymphocyte Therapy in an Evolving Landscape of Immunotherapy.

Published in:

Journal of Clinical Medicine, 2025, v. 14, n. 4, p. 1200, doi. 10.3390/jcm14041200

By:

Mehta, Apoorva;
Motavaf, Mateen;
Nebo, Ikenna;
Luyten, Sophia;
Osei-Opare, Kofi D.;
Gru, Alejandro A.

Publication type:

Article

From Biology to Clinical Practice: The Bone Marrow Microenvironment in Multiple Myeloma.

Published in:

Journal of Clinical Medicine, 2025, v. 14, n. 2, p. 327, doi. 10.3390/jcm14020327

By:

Fotiou, Despina;
Katodritou, Eirini

Publication type:

Article